Wave Life Sciences Ltd. (WVE) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-03-31

Wave Life Sciences Ltd. (WVE) — no SEC Form 4 insider filings recorded in the last 90 days. 4 Form 8-K material event filings were reported by WVE in the last 90 days. InsiderAlpha tracks every WVE SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Wave Life Sciences Ltd. (WVE)

SEC CIK	0001631574

90-Day SEC Filing Activity

Form 8-K filings (90d)	4
Latest Form 4 filing	2026-03-31

Recent WVE Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-03-30	RA CAPITAL MANAGEMENT, L.P.	Insider	P — Open-market purchase	971.1K	$6.50	$6.31M	SEC
2026-03-27	RA CAPITAL MANAGEMENT, L.P.	Insider	P — Open-market purchase	2.50M	$6.43	$16.05M	SEC
2026-03-26	RA CAPITAL MANAGEMENT, L.P.	Insider	P — Open-market purchase	4.95M	$6.06	$30.02M	SEC
2026-03-26	RA CAPITAL MANAGEMENT, L.P.	Insider	P — Open-market purchase	351.2K	$6.38	$2.24M	SEC
2026-03-23	TAKANASHI KEN	Insider	J — Other acquisition / disposition	3.90M	$0.00	—	SEC
2026-02-26	Francis Chris	See Remarks	S — Open-market sale [10b5-1]	15.3K	$15.00	$229K	SEC
2026-02-26	Francis Chris	See Remarks	M — Option exercise [10b5-1]	17.9K	$3.87	$69K	SEC
2026-02-26	Francis Chris	See Remarks	S — Open-market sale [10b5-1]	17.9K	$15.09	$270K	SEC
2026-02-26	Francis Chris	See Remarks	M — Option exercise [10b5-1]	15.3K	$4.75	$73K	SEC
2026-02-09	Moran Kyle	Chief Financial Officer	S — Open-market sale	3.6K	$13.45	$48K	SEC
2026-02-09	Vargeese Chandra	See Remarks	S — Open-market sale	3.2K	$13.45	$43K	SEC
2026-02-09	Francis Chris	See Remarks	S — Open-market sale	1.9K	$13.45	$25K	SEC
2026-02-09	BOLNO PAUL	President and CEO	S — Open-market sale	10.5K	$13.45	$141K	SEC
2026-02-05	Moran Kyle	Chief Financial Officer	A — Grant or award	45.6K	$0.00	—	SEC
2026-02-05	BOLNO PAUL	President and CEO	A — Grant or award	165.0K	$0.00	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Wave Life Sciences Ltd. (WVE). Updated in real time as new filings are submitted to the SEC.

Recent WVE Form 8-K Material Events

2026-06-26 — Item 5.07 [SEC]
2026-05-18 — Item 7.01, 8.01, 9.01 [SEC]
2026-04-28 — Item 2.02, 7.01, 9.01 [SEC]
2026-04-21 — Item 8.01, 9.01 · Other · neutral [SEC]
Wave Life Sciences Ltd. announced a hearing on its proposed redomiciliation from Singapore to the United States. The company filed a press release and is preparing to solicit shareholder votes on the corporate restructuring through a definitive proxy statement.
2026-04-15 — Item 1.01, 8.01, 9.01 · Acquisition · neutral [SEC]
Wave Life Sciences Ltd. announced a corporate redomiciliation whereby the Singapore parent company will restructure to become a Delaware corporation through a scheme of arrangement. All Wave-Singapore ordinary shares will be exchanged on a one-for-one basis for Wave-Delaware comm

Recent Insider Filings

2026-03-31 — RA CAPITAL MANAGEMENT, L.P. (Insider)
2026-03-26 — TAKANASHI KEN (Insider)
2026-02-28 — Francis Chris (See Remarks)
2026-02-12 — Moran Kyle (Chief Financial Officer)
2026-02-12 — BOLNO PAUL (President and CEO)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in WVE insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

WVE Insider Trading — FAQ

What is the latest insider trade for WVE?: Wave Life Sciences Ltd. (WVE) had 0 insider filings in the last 90 days, with the most recent on 2026-03-31. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying WVE stock?: 0 insider purchases of WVE were filed in the last 90 days.
How many insiders are selling WVE stock?: 0 insider sales of WVE were filed in the last 90 days.
Where can I see WVE SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every WVE SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live WVE dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.